Cambridge researchers use artificial intelligence to help detect early stage cancer.
The Medicine for Members lecture: Cambridge Cancer – Rewriting the story will take place on Wednesday 19 May 2021
Artificial intelligence could ease pressures on diagnostic services for precancerous condition, Barrett’s oesophagus
The meeting held on Tuesday 21st April is titled: “Oncology Therapeutics: Use of AI and Machine Learning Across the Discovery Workflow”
Thursday 22nd and Friday 23rd April 2021.
Dr Shubha Anand and Dr Ezequiel Martin Rodriguez highlight the work of the Cancer Molecular Diagnostics Laboratory (CMDL). CMDL supports all of the MFICM clinical trials and studies.
Duncan Jodrell discusses the MFICM supported ATRiUM clinical trial for pancreatic cancer.
James Brenton, Mireia Crispin-Ortuzar and Ramona Woitek discuss MFICM supported research: integrated radiogenomics for virtual biopsy and treatment monitoring in ovarian cancer.
